Emalex Biosciences Inc.
- Address
- 330 North Wabash Avenue Suite 3500
Sponsor Overview
Specializations
Tourette’s Disorder Research
Emalex Biosciences Inc. concentrates its clinical research on Tourette’s Disorder, with studies spanning children, adolescents, and adults affected by tic-related symptoms.
- Tic symptom control
- Maintenance of efficacy
- Long-term treatment response
The sponsor’s portfolio reflects a focused interest in neurological conditions associated with motor tics and vocal tics, with active research sites across multiple countries.
Paediatric and Adolescent Neurology
Clinical activity includes treatment evaluation in younger populations, particularly paediatric and adolescent patients with Tourette’s Disorder.
- Childhood-onset tic disorders
- Adolescent neurological care
- Age-specific tolerability
These studies address neurological symptoms across developmental stages, including patients enrolled from international research centres.
Adult Tourette’s Disorder Care
The sponsor also includes adult participants in its Tourette’s Disorder research, extending clinical interest beyond paediatric populations.
- Persistent tic symptoms
- Adult safety monitoring
- Ongoing symptom management
This area supports investigation of treatment use across the full age spectrum of the disorder.
Neurological Therapeutics
Emalex Biosciences’ funded trials are centred on neurological therapeutics for tic disorders, with attention to sustained clinical benefit and patient tolerability.
- Symptom stabilization
- Safety and tolerability
- Long-term management strategies
The research footprint includes multiple collaborating sites and active recruitment across several countries.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Ecopipam Hydrochloride for Maintenance of Efficacy in Pediatric and Adolescent Patients with Tourette's Disorder: A Randomized, Double-Blind Study |  Bulgaria Denmark France Germany Hungary Italy Poland Romania Spain | Not Recruiting |
| Long-Term Safety Evaluation of Ecopipam Hydrochloride Tablets in Pediatric, Adolescent, and Adult Patients with Tourette's Disorder | Bulgaria Denmark France Germany Hungary Italy Poland Spain | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 36 sites across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases2 trials449 other sponsors
Partnered Research Centres
36 centres- Address
- Via Don Luigi Monza 1, 22037 Ponte Lambro
- Address
- Via Sergio Pansini 5, 80131 Naples
- Address
- Via Santa Sofia 78, 95123 Catania
- Address
- Luisenring J 5, 68159 Mannheim
- Address
- Ul. 28 Czerwca 1956 R. 194, 61-485 Poznan
- Address
- Ul. Ul. Ludwika Solskiego 4a/1, 52-416 Wroclaw
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Emalex Biosciences Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.